Gepirone hydrochloride

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameGepirone hydrochloride
Drug Alias Name吉哌隆Gepirone ERVarizaTravivoEXXUA +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorCocaine-Related DisordersHeart Failure +[4] 
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/09/22
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesFabre-Kramer
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgSarfez Pharmaceuticals IncJanssen Research & Development Llc +[4] 
Active IndicationsDepressive Disorder, Major
Inactive IndicationsCocaine-Related DisordersHeart FailureRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A